Latest Stock Buy or Sell? Make More Informed Decisions!

US valuations are too high. Remove the Magnificent 7 from the S&P 500 and you discover those 493 stocks are trading 3-4 multiple turns lower than the S&P headline number. Financials and select healthcare and energy are good sectors to go. He is slightly underweight the Mag 7; he holds 20 stocks at an average weighting of 5%. 2025 will be a stockpicker's market, not for passive investors.

The US has become the swing producer and less reliant on OPEC. Oil prices are tepid, given China being weak among other factors. Oil companies have reduced operational costs, so they are now more profitable and producing more cash. Yields are higher. He sees the opportunity for higher profits if oil prices rise. He owns no oil stocks now.

It's the best bank in the world, boasting size and scale and trading at 2x book, which is historical expensive.

Owns this and JPM. Trades at a much cheaper 70% of book vs. JPM's 2x book.

He bought this and other homebuilders in 2009 during the crisis and still owns them. They remain great performers. The US remains 5 million housing units short, unable to keep up with immigration. However, labour is about to get very tough, if Trump follows through with expelling undocumented workers, many of who work in this sector.

He likes that it's trading at lower and lower valuations. He sold this as shares ran up, because expectations were exhuberant and when investors felt that the company's AI wasn't growing fast enough. But he may move back into this at $450.

They've missed out on their quality targets, and they have poor timing. They just changed their CEO. They spend a lot of money on R&D, but enjoy weak returns. There are better semi stocks out there. 

Some feel that this stock can only go down, but that's too simple. Yes, they will lose market share in search, but that overall market could expand 2-4x larger, which creates fantastic advertising opportunities. What they're doing with Gemini and Google and AI is exciting; it has legs.

The entire US health insurance group is embroiled in a controversy that was unfortunately set off by the murder of UNH, specifically talk about how claims are treated at UNH. These stocks are falling, but hang on and let this pass and see how different parties react. There will always be a place for health insurance companies in the US.

See UNH comments. The whole US health insurance industry is in turmoil. The industry itself admits there's a problem with how claims are processed and need to be fixed. These companies are necessary in the US health system, and they are for-profit. ELV hasn't traded at this low a valuation since 2013. Hold on.

The new US administration is talking tough about health cost controls, certainly more extreme than in the past. MRK's Keytruda is a blockbuster drug that has a few years to go before the patent ends. Healthcare has been out of favour the past year, but he recommends holding on.

Share had dipped because contaminants had gotten into a system, so he put during that momentary weakness. He likes their mix of commercial and defence industries.

The 4th-largest P&C insurer in the world. They do well underwriting and in investing as well. Their combined ratio is 86%, impressive. They also make money on their bond holdings. Berkshire Hathaway owns a large position. Also, CB is low-volatility and defensive.

They were blowing away expectations is recent quarters, but this raised the bar so high that disappointment is inevitable. Shares have returned to levels of last July, but so has the Magnificent 7. The Mag 7 has run up so much, that they need a rest. Also, competition will inevitably limit margins and revenues.

It doesn't fit his company and clients. PLTR is too risky. He couldn't sleep at night owning this. The trailing 195x valuation is excessive. True, this stock can continue to rise, but it wouldn't change his mind.